Regulatory Compliance

Cardiol Therapeutics Files US$150M Shelf Prospectus, Expands OSC Disclosure

Toronto – September 17, 2026 -- Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) has filed a preliminary short form base shelf prospectus in Canada and a corresponding Form F-10 registration statement with the U.S. SEC, enabling the life sciences company to raise up to US$150 million over a 25-month period.

Shelf filing permits future issuance of shares, debt and warrants

The filings, made under the U.S./Canada Multijurisdictional Disclosure System, would allow Cardiol to offer Class A common shares, debt securities, warrants, subscription receipts, units, or combinations thereof, once a final receipt is issued and the Registration Statement becomes effective. No securities are being offered under this announcement, and the Company said there is no assurance an offering will occur.

CPSC Names Paul Brubaker Executive Director, Chief Operating Officer

Washington, D.C. – September 17, 2026 -- The U.S. Consumer Product Safety Commission has appointed Paul Brubaker as its new Executive Director, installing him as the agency's chief operating officer over programmatic, operational, and administrative functions.

Brubaker takes charge of CPSC's regulatory portfolio and hazard-response operations

Brubaker will manage CPSC's regulatory portfolio and help direct efforts to identify and address consumer product hazards. He brings nearly four decades of public and private sector leadership in technology, cybersecurity, data analytics, organizational strategy, and federal management.

Havoc, CSBC Taiwan Partner on Autonomous Vessel Co-Production

Providence, R.I. – September 17, 2026 -- Havoc, a U.S. collaborative autonomy company, and CSBC Corporation, Taiwan, the island's largest shipbuilder, have signed a partnership to pursue licensed co-production of autonomous surface vessels (ASVs) for Taiwan's maritime security.

Partnership pairs U.S. autonomy software with Taiwan-built hulls

Under the agreement, Havoc's collaborative autonomy software will be integrated onto ASV platforms built by CSBC in Taiwan, with production and lifecycle sustainment handled locally. The deal targets Taiwan's domestic shipbuilding capacity, headquartered in Kaohsiung with shipyards in Kaohsiung and Keelung, founded in 1973.

CTI's Crystal Risotti Named Pinnacle Professional by The Inner Circle

Indianapolis – September 17, 2026 -- Crystal Risotti, Senior Manager of Validation in Quality Assurance at CTI, has been named a Pinnacle Professional of the Year by The Inner Circle for her three-decade career in information technology quality assurance and regulatory compliance across pharmaceuticals, medical devices and clinical laboratories.

Risotti built her career from clinical trial lab work in 1990 to enterprise-wide compliance leadership

Risotti entered the pharmaceutical industry in 1990 as a clinical trials laboratory worker before moving through customer service, project management, training and Tier 4 help desk roles. She later specialized in software development life cycle consultation, 21 CFR Part 11 compliance, and electronic quality management system implementation, working remotely from Indianapolis, Indiana while based at CTI's Covington, Kentucky office.

Lode Gold Expands Fremont Drill Program With Four New Pads

Vancouver – September 17, 2026 -- Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: LODFF) has expanded its drill program at the 100%-owned Fremont Gold Mine in Mariposa County, California, adding four new drill pads through an amendment to its existing Authorized Use Permit rather than seeking a new regulatory approval.

Four new pads target metallurgy, hydrogeology and untested ground

The expanded scope adds pads PT-J 011, PT-J 012, HGD-002 and HGD-003. Pads PT-J 011 and PT-J 012 will collect PQ-diameter metallurgical core samples to refine recovery mapping and geometallurgical domain modeling ahead of future feasibility work. Pads HGD-002 and HGD-003 are vertical hydrogeological holes designed for in-situ permeability testing and baseline hydrological monitoring required for mine planning.

USFCR Named Federal Contracting Services of the Year 2026

Clearwater, Fla. – September 17, 2026 -- US Federal Contractor Registration (USFCR) has been named Federal Contracting Services of the Year 2026 by the Editorial Board of Gov Business Review, a recognition dated August 2026 that credits the firm's model for preparing businesses to compete in the federal marketplace.

Gov Business Review ties the award to a structured index of contractor performance

The publication determined the recognition through its Government Business Performance and Value Index, combined with independent editorial research, subscriber nominations and industry input. Evaluation criteria included government use-case alignment, execution in regulated contracting environments, measurable public sector impact and institutional confidence.

Hikma's Epinephrine Nasal Spray Advances Through FDA, EU, UK Review

London – September 17, 2026 -- Hikma Pharmaceuticals PLC said regulators in the United States, Europe, and the UK have accepted for review its investigational epinephrine nasal spray, a needle-free treatment for anaphylaxis, with an additional filing lodged in Canada.

FDA accepts 505(b)(2) application for non-injectable anaphylaxis treatment

The US Food and Drug Administration has taken up a New Drug Application submitted under the 505(b)(2) pathway, which includes the required non-clinical and clinical data package supporting approval of the nasal spray for emergency anaphylaxis treatment.

APTIM Wins $145M Navy Fuel Infrastructure Engineering Contract

Baton Rouge, La. – September 17, 2026 -- APTIM has been selected for a $145 million Indefinite Delivery/Indefinite Quantity Multiple Award Contract with the US Department of the Navy to provide Architect-Engineer services for Petroleum, Oils, and Lubricants (POL) systems worldwide, with work scheduled through August 2031.

NAVFAC EXWC awards APTIM engineering role covering global fuel infrastructure

The contract, administered by the Naval Facilities Engineering and Expeditionary Warfare Center (NAVFAC EXWC), covers engineering and design services for POL systems and supporting facilities at Navy and Marine Corps installations globally.

Fenix24 Named Gartner Cool Vendor for Argos99 Recovery Platform

Chattanooga, Tenn. – September 17, 2026 -- Fenix24 has been named a Cool Vendor in the Gartner Coolest Vendor Innovations in Cyber Resilience report for its Argos99 Cyber Resilience and Recovery Intelligence Platform.

Gartner projects 30% of large enterprises will deploy dedicated cyber resilience platforms by 2029

Gartner's report, authored by Arthur Sivanathan, Wayne Hankins and Niyati Daftary and published September 17, 2026, forecasts that by 2029, 30% of large enterprises will deploy dedicated cyber resilience platforms that continuously validate recovery readiness and orchestrate business-led incident response.

Helix Launches WES+ Test Combining Exome, Mitochondrial, Karyotype Analysis

San Mateo, Calif. – September 16, 2026 -- Helix has launched Whole Exome+ Sequencing (WES+), a diagnostic test that combines exome sequencing, mitochondrial genome analysis, and genome-wide digital karyotype into a single order for patients with unexplained developmental delay, neurological conditions, and rare genetic disease.

WES+ integrates four diagnostic capabilities in one order

The test covers 99% of clinically relevant exome regions, includes mitochondrial testing that other labs typically bill as a separate add-on, and performs high-resolution chromosomal copy number analysis via a digital karyotype. Helix says the digital karyotype feature may eliminate the need for a standalone chromosomal microarray (CMA) in many clinical scenarios, though the company notes CMA or additional cytogenetic testing may still be clinically indicated in some cases.